Vir Biotechnology, Inc. VIR Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s operating lease right-of-use assets in other assets?
- Vir Biotechnology, Inc. (VIR) reported operating lease right-of-use assets in other assets of $60.76M in Q1 2026.
- How has Vir Biotechnology, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Vir Biotechnology, Inc.'s operating lease right-of-use assets in other assets increased by 3.8% year-over-year, from $58.56M to $60.76M.
- What is the long-term trend for Vir Biotechnology, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s operating lease right-of-use assets in other assets has grown at a 0.0% compound annual growth rate (CAGR), from $61.95M to $62.1M.